Troy Edward Wilson's Net Worth
$39.2 Million
Who is Troy Edward Wilson?
Troy Edward Wilson has an estimated net worth of $39.2 Million. This is based on reported shares across multiple companies, which include Kura Oncology, Inc., Zosano Pharma Corp, Avidity Biosciences, Inc., and PUMA BIOTECHNOLOGY, INC..
SEC CIK
Troy Edward Wilson's CIK is 0001589597
Past Insider Trading and Trends
2020 was Troy Edward Wilson's most active year for acquiring shares with 18 total transactions. Troy Edward Wilson's most active month to acquire stocks was the month of May. 2020 was Troy Edward Wilson's most active year for disposing of shares, totalling 37 transactions. Troy Edward Wilson's most active month to dispose stocks was the month of July. 2024 saw Troy Edward Wilson paying a total of $550,594.05 for 91,052 shares, this is the most they've acquired in one year. In 2020 Troy Edward Wilson cashed out on 1,501,494 shares for a total of $16,988,228.85, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kura Oncology, Inc. (KURA) Snapshot price: $20.65
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$13.14 | -$1,291,387.91 | 559 |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| -1.06% | -3.00K |
—
|
—
| 279.75K |
Dec 7
| |||
Form 4
| -49.96% | -581.78K |
—
|
—
| 582.75K |
Jun 2
| |||
Form 4
| -29.95% | -497.99K |
—
|
—
| 1.16M |
Jul 14 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -9.75% | -175.00K |
—
|
—
| 1.62M |
Dec 23 - Jan 26
| |||
Form 4
| +42.19% | 11.86K |
$6.15 | $72,908.25 | 39.95K |
Dec 1
| |||
Form 4
| -88.04% | -206.74K |
$19.84 | -$8,359,548.60 | 28.1K |
Scheduled
|
Oct 6 - Oct 8
| ||
Form 4
| -29.65% | -98.97K |
$17.28 | -$3,244,138.86 | 234.83K |
Scheduled
|
Sep 11 - Sep 14
| ||
Form 4
| -13.26% | -51.02K |
$16.59 | -$2,137,805.50 | 333.81K |
Scheduled
|
Sep 8 - Sep 10
| ||
Form 4
|
—
|
0
|
$14.07 | -$487,545.61 | 28.1K |
Scheduled
|
Aug 24 - Aug 25
| ||
Form 4
| -2.24% | -50.00K |
$13.42 | -$1,536,918.74 | 2.18M |
Scheduled
|
Aug 17 - Aug 19
| ||
Form 4
| +107.89% | 28.1K |
$4.86 | $136,460.55 | 54.14K |
Feb 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +78.95% | 26.04K |
$4.80 | $124,996.80 | 59.03K |
Nov 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
| +559.70% | 27.98K |
$4.80 | $134,328.00 | 32.98K |
Aug 22
| |||
Form 4
|
∞
| 5K |
$4.80 | $24,000.00 | 5K |
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zosano Pharma Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Avidity Biosciences, Inc. (RNA) Snapshot price: $12.19
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
| 613.71K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
| 189.62K |
Dec 22
| |||
Form 4
| +30.68% | 189.04K |
—
|
—
| 805.3K |
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PUMA BIOTECHNOLOGY, INC. (PBYI) Snapshot price: $5.035
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$3.45 | -$93,268.80 | 27.35K |
Jun 13
| |||
Form 4
| -50.46% | -27.86K |
$2.58 | -$71,971.14 | 27.35K |
Scheduled
|
Jun 16
| ||
Form 4
| +95.72% | 27K |
—
|
—
| 55.21K |
Jun 14
| |||
Form 4
| +7,959.43% | 27.86K |
—
|
—
| 28.21K |
Jun 15
| |||
Form 4
| -98.66% | -25.75K |
$11.36 | -$292,432.91 | 350 |
Jun 10
| |||
Form 4
| -49.17% | -25.25K |
$9.97 | -$251,692.65 | 26.1K |
Jun 11
| |||
Form 4
| +100.60% | 25.75K |
—
|
—
| 51.34K |
Jun 9
| |||
Form 4
| +314.70% | 19.42K |
—
|
—
| 25.59K |
Jun 10
| |||
Form 4
| +1,663.43% | 5.82K |
—
|
—
| 6.17K |
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||